Current Applications of Antibody Microarrays

Overview

Journal Clin Proteomics

Publisher Biomed Central

Date 2018 Mar 7

PMID 29507545

Citations 30

Authors

Ziqing Chen

Tea Dodig-Crnkovic

Jochen M Schwenk

Sheng-Ce Tao

Affiliations

Soon will be listed here.

Abstract

The concept of antibody microarrays is one of the most versatile approaches within multiplexed immunoassay technologies. These types of arrays have increasingly become an attractive tool for the exploratory detection and study of protein abundance, function, pathways, and potential drug targets. Due to the properties of the antibody microarrays and their potential use in basic research and clinical analytics, various types of antibody microarrays have already been developed. In spite of the growing number of studies utilizing this technique, few reviews about antibody microarray technology have been presented to reflect the quality and future uses of the generated data. In this review, we provide a summary of the recent applications of antibody microarray techniques in basic biology and clinical studies, providing insights into the current trends and future of protein analysis.

Citing Articles

Allergen Microarrays and New Physical Approaches to More Sensitive and Specific Detection of Allergen-Specific Antibodies.

Sokolov P, Evsegneeva I, Karaulov A, Sukhanova A, Nabiev I Biosensors (Basel). 2024; 14(7).

PMID: 39056629 PMC: 11275078. DOI: 10.3390/bios14070353.

Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the Proteome.

Kraemer S, Schneider D, Paterson C, Perry D, Westacott M, Hagar Y J Proteome Res. 2024; 23(11):4771-4788.

PMID: 39038188 PMC: 11536431. DOI: 10.1021/acs.jproteome.4c00411.

Stem Cells and Acellular Preparations in Bone Regeneration/Fracture Healing: Current Therapies and Future Directions.

Brown M, Brady D, Healy K, Henry K, Ogunsola A, Ma X Cells. 2024; 13(12.

PMID: 38920674 PMC: 11201612. DOI: 10.3390/cells13121045.

Phosphoproteome Microarray Analysis of Extracellular Particles as a Tool to Explore Novel Biomarker Candidates for Alzheimer's Disease.

Soares Martins T, Pelech S, Ferreira M, Pinho B, Leandro K, de Almeida L Int J Mol Sci. 2024; 25(3).

PMID: 38338863 PMC: 10855802. DOI: 10.3390/ijms25031584.

Enzymatic Protein Immobilization for Nanobody Array.

Lu Z, Ge R, Zheng B, Zheng P Molecules. 2024; 29(2).

PMID: 38257279 PMC: 10820937. DOI: 10.3390/molecules29020366.

References

Pauly F, Smedby K, Jerkeman M, Hjalgrim H, Ohlsson M, Rosenquist R . Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays. Leuk Res. 2014; 38(6):682-90. DOI: 10.1016/j.leukres.2014.03.010. View

Hu W, Liu Y, Chen T, Liu Y, Li C . Hybrid ZnO nanorod-polymer brush hierarchically nanostructured substrate for sensitive antibody microarrays. Adv Mater. 2014; 27(1):181-5. DOI: 10.1002/adma.201403712. View

Taussig M, Schmidt R, Cook E, Stoevesandt O . Development of proteome-wide binding reagents for research and diagnostics. Proteomics Clin Appl. 2013; 7(11-12):756-66. DOI: 10.1002/prca.201300060. View

Remnestal J, Just D, Mitsios N, Fredolini C, Mulder J, Schwenk J . CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease. Proteomics Clin Appl. 2016; 10(12):1242-1253. PMC: 5157753. DOI: 10.1002/prca.201500150. View

Rucker V, Havenstrite K, Herr A . Antibody microarrays for native toxin detection. Anal Biochem. 2005; 339(2):262-70. DOI: 10.1016/j.ab.2005.01.030. View

Haggmark A, Bystrom S, Ayoglu B, Qundos U, Uhlen M, Khademi M . Antibody-based profiling of cerebrospinal fluid within multiple sclerosis. Proteomics. 2013; 13(15):2256-67. DOI: 10.1002/pmic.201200580. View

Boucher J, Kleinridders A, Kahn C . Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014; 6(1). PMC: 3941218. DOI: 10.1101/cshperspect.a009191. View

Gujral T, Karp R, Finski A, Chan M, Schwartz P, MacBeath G . Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays. Oncogene. 2012; 32(29):3470-6. PMC: 3670968. DOI: 10.1038/onc.2012.378. View

Mahlknecht P, Stemberger S, Sprenger F, Rainer J, Hametner E, Kirchmair R . An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes. Proteome Sci. 2012; 10(1):71. PMC: 3539904. DOI: 10.1186/1477-5956-10-71. View

10.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

11.

Bezprozvanny I . Calcium signaling and neurodegenerative diseases. Trends Mol Med. 2009; 15(3):89-100. PMC: 3226745. DOI: 10.1016/j.molmed.2009.01.001. View

12.

Berrade L, Garcia A, Camarero J . Protein microarrays: novel developments and applications. Pharm Res. 2010; 28(7):1480-99. PMC: 3137928. DOI: 10.1007/s11095-010-0325-1. View

13.

Ivanov S, Chung A, Yuan Z, Guan Y, Sachs K, Reichner J . Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Mol Cell Proteomics. 2004; 3(8):788-95. DOI: 10.1074/mcp.M300130-MCP200. View

14.

Juncker D, Bergeron S, Laforte V, Li H . Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing. Curr Opin Chem Biol. 2014; 18:29-37. DOI: 10.1016/j.cbpa.2013.11.012. View

15.

Neiman M, Fredolini C, Johansson H, Lehtio J, Nygren P, Uhlen M . Selectivity analysis of single binder assays used in plasma protein profiling. Proteomics. 2013; 13(23-24):3406-10. PMC: 4265267. DOI: 10.1002/pmic.201300030. View

16.

Zhang D, Qin Y . The paradox of elongation factor 4: highly conserved, yet of no physiological significance?. Biochem J. 2013; 452(2):173-81. DOI: 10.1042/BJ20121792. View

17.

Schroder C, Jacob A, Tonack S, Radon T, Sill M, Zucknick M . Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol Cell Proteomics. 2010; 9(6):1271-80. PMC: 2877986. DOI: 10.1074/mcp.M900419-MCP200. View

18.

Stoevesandt O, Taussig M . European and international collaboration in affinity proteomics. N Biotechnol. 2012; 29(5):511-4. DOI: 10.1016/j.nbt.2012.05.003. View

19.

Sanchez-Carbayo M . Antibody microarrays as tools for biomarker discovery. Methods Mol Biol. 2011; 785:159-82. DOI: 10.1007/978-1-61779-286-1_11. View

20.

Skoog P, Ohlsson M, Ferno M, Ryden L, Borrebaeck C, Wingren C . Tumor tissue protein signatures reflect histological grade of breast cancer. PLoS One. 2017; 12(6):e0179775. PMC: 5484475. DOI: 10.1371/journal.pone.0179775. View